Association of salivary testosterone levels during the post-awakening period with age and symptoms suggestive of late-onset hypogonadism in men

References

• Bagatell CJ, Bremner WJ. Androgens in men–uses and abuses. N Engl J Med. 1996;334(11):707–714. doi: 10.1056/NEJM199603143341107.
   PubMed Web of Science ®Google Scholar
• Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev. 2005;26(6):833–876. doi: 10.1210/er.2004-0013.
   PubMed Web of Science ®Google Scholar
• Araujo AB, Esche GR, Kupelian V, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92(11):4241–4247. doi: 10.1210/jc.2007-1245.
   PubMed Web of Science ®Google Scholar
• Harman SM, Metter EJ, Tobin JD, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore longitudinal study of aging. J Clin Endocrinol Metab. 2001;86(2):724–731.
   PubMed Web of Science ®Google Scholar
• Huhtaniemi I. Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment. Asian J Androl. 2014;16(2):192–202. doi: 10.4103/1008-682X.122336.
   PubMed Web of Science ®Google Scholar
• Miwa Y, Kaneda T, Yokoyama O. Correlation between the aging males’ symptoms scale and sex steroids, gonadotropins, dehydroepiandrosterone sulfate, and growth hormone levels in ambulatory men. J Sex Med. 2006;3(4):723–726. doi: 10.1111/j.1743-6109.2006.00277.x.
   PubMed Web of Science ®Google Scholar
• T'Sjoen G, Goemaere S, De Meyere M, et al. Perception of males’ aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels. Psychoneuroendocrinology. 2004;29(2):201–214. doi: 10.1016/s0306-4530(03)00023-4.
   PubMed Web of Science ®Google Scholar
• Spetz AC, Palmefors L, Skobe RS, et al. Testosterone correlated to symptoms of partial androgen deficiency in aging men (PADAM) in an elderly Swedish population. Menopause. 2007;14(6):999–1005. doi: 10.1097/gme.0b013e318057786b.
   PubMed Web of Science ®Google Scholar
• Morley JE, Perry HM, 3rd, Kevorkian RT, et al. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas. 2006;53(4):424–429. doi: 10.1016/j.maturitas.2005.07.004.
   PubMed Web of Science ®Google Scholar
• Basar MM, Aydin G, Mert HC, et al. Relationship between serum sex steroids and aging male symptoms score and international index of erectile function. Urology. 2005;66(3):597–601. doi: 10.1016/j.urology.2005.03.060.
   PubMed Web of Science ®Google Scholar
• Chen W, Liu ZY, Wang LH, et al. Are the aging male’s symptoms (AMS) scale and the androgen deficiency in the aging male (ADAM) questionnaire suitable for the screening of late-onset hypogonadism in aging Chinese men? Aging Male. 2013;16(3):92–96. doi: 10.3109/13685538.2013.805319.
   PubMed Web of Science ®Google Scholar
• Cooke RR, McIntosh JE, McIntosh RP. Circadian variation in serum free and non-SHBG-bound testosterone in normal men: measurements, and simulation using a mass action model. Clin Endocrinol (Oxf). 1993;39(2):163–171. doi: 10.1111/j.1365-2265.1993.tb01769.x.
   PubMed Web of Science ®Google Scholar
• Diver MJ, Imtiaz KE, Ahmad AM, et al. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol (Oxf). 2003;58(6):710–717.
   PubMed Web of Science ®Google Scholar
• Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol. 2008;159(5):507–514. doi: 10.1530/EJE-08-0601.
   PubMed Web of Science ®Google Scholar
• Debono M, Ghobadi C, Rostami-Hodjegan A, et al. Modified-release hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab. 2009;94(5):1548–1554. doi: 10.1210/jc.2008-2380.
   PubMed Web of Science ®Google Scholar
• Pruessner JC, Wolf OT, Hellhammer DH, et al. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 1997;61(26):2539–2549. doi: 10.1016/s0024-3205(97)01008-4.
   PubMed Web of Science ®Google Scholar
• Wilhelm I, Born J, Kudielka BM, et al. Is the cortisol awakening rise a response to awakening? Psychoneuroendocrinology. 2007;32(4):358–366. doi: 10.1016/j.psyneuen.2007.01.008.
   PubMed Web of Science ®Google Scholar
• Clow A, Hucklebridge F, Stalder T, et al. The cortisol awakening response: more than a measure of HPA axis function. Neurosci Biobehav Rev. 2010;35(1):97–103.
   PubMed Web of Science ®Google Scholar
• Ishida A, Mutoh T, Ueyama T, et al. Light activates the adrenal gland: timing of gene expression and glucocorticoid release. Cell Metab. 2005;2(5):297–307. doi: 10.1016/j.cmet.2005.09.009.
   PubMed Web of Science ®Google Scholar
• Ahn RS, Choi JH, Choi BC, et al. Cortisol, estradiol-17β, and progesterone secretion within the first hour after awakening in women with regular menstrual cycles. J Endocrinol. 2011;211(3):285–295. doi: 10.1530/JOE-11-0247.
   PubMed Web of Science ®Google Scholar
• Kang JY, Park JY, Chun SI, et al. Puberty-related changes in cortisol, dehydroepiandrosterone, and estradiol-17β secretions within the first hour after waking in premenarcheal girls. Neuroendocrinology. 2014;99(3-4):168–177. doi: 10.1159/000363368.
   PubMed Web of Science ®Google Scholar
• Heinemann LAJ, Zimmermann T, Vermeulen A, et al. A new ‘aging males’ symptoms’ rating scale. Aging Male. 1999;2:105–114.
   Google Scholar
• Wood P. Salivary steroid assays - research or routine? Ann Clin Biochem. 2009;46(Pt 3):183–196. doi: 10.1258/acb.2008.008208.
   PubMedGoogle Scholar
• Jo KB, Lee YJ, Lee IG, et al. Association of pain intensity, pain-related disability, and depression with hypothalamus-pituitary-adrenal axis function in female patients with chronic temporomandibular disorders. Psychoneuroendocrinology. 2016;69:106–115. doi: 10.1016/j.psyneuen.2016.03.017.
   PubMed Web of Science ®Google Scholar
• Stalder T, Kirschbaum C, Kudielka BM, et al. Assessment of the cortisol awakening response: expert consensus guidelines. Psychoneuroendocrinology. 2016;63:414–432. doi: 10.1016/j.psyneuen.2015.10.010.
   PubMed Web of Science ®Google Scholar
• Gröschl M, Wagner R, Rauh M, et al. Stability of salivary steroids: the influences of storage, food and dental care. Steroids. 2001;66(10):737–741. doi: 10.1016/s0039-128x(01)00111-8.
   PubMed Web of Science ®Google Scholar
• Corrie JE, Hunter WM, Macpherson JS. A strategy for radioimmunoassay of plasma progesterone with use of a homologous-site 125I-labeled radioligand. Clin Chem. 1981;27(4):594–599. doi: 10.1093/clinchem/27.4.594.
   PubMed Web of Science ®Google Scholar
• Dettenborn L, Rosenloecher F, Kirschbaum C. No effects of repeated forced wakings during three consecutive nights on morning cortisol awakening responses (CAR): a preliminary study. Psychoneuroendocrinology. 2007;32(8-10):915–921. doi: 10.1016/j.psyneuen.2007.06.011.
   PubMed Web of Science ®Google Scholar
• Federenko I, Wüst S, Hellhammer DH, et al. Free cortisol awakening responses are influenced by awakening time. Psychoneuroendocrinology. 2004;29(2):174–184. doi: 10.1016/s0306-4530(03)00021-0.
   PubMed Web of Science ®Google Scholar
• Wust S, Wolf J, Hellhammer DH, et al. The cortisol awakening response - normal values and confounds. Noise Health. 2000;2(7):79–88.
   PubMedGoogle Scholar
• Okun ML, Krafty RT, Buysse DJ, et al. What constitutes too long of a delay? Determining the cortisol awakening response (CAR) using self-report and PSG-assessed wake time. Psychoneuroendocrinology. 2009;35(3):460–468. doi: 10.1016/j.psyneuen.2009.08.017.
   PubMed Web of Science ®Google Scholar
• Dockray S, Bhattacharyya MR, Molloy GJ, et al. The cortisol awakening response in relation to objective and subjective measures of waking in the morning. Psychoneuroendocrinology. 2008;33(1):77–82. doi: 10.1016/j.psyneuen.2007.10.001.
   PubMed Web of Science ®Google Scholar
• Stalder T, Lupien SJ, Kudielka BM, et al. Evaluation and update of the expert consensus guidelines for the assessment of the cortisol awakening response (CAR). Psychoneuroendocrinology. 2022;146:105946. doi: 10.1016/j.psyneuen.2022.105946.
   PubMed Web of Science ®Google Scholar
• Stalder T, Bäumler D, Miller R, et al. The cortisol awakening response in infants: ontogeny and associations with development-related variables. Psychoneuroendocrinology. 2013;38(4):552–559. doi: 10.1016/j.psyneuen.2012.07.015.
   PubMed Web of Science ®Google Scholar
• Handelsman DJ, Yeap B, Flicker L, et al. Age-specific population centiles for androgen status in men. Eur J Endocrinol. 2015;173(6):809–817. doi: 10.1530/EJE-15-0380.
   PubMed Web of Science ®Google Scholar
• Tan RS, Philip PS. Perceptions of and risk factors for andropause. Arch Androl. 1999;43(3):227–233. doi: 10.1080/014850199262544.
   PubMed Web of Science ®Google Scholar
• Miyatake A, Morimoto Y, Oishi T, et al. Circadian rhythm of serum testosterone and its relation to sleep: comparison with the variation in serum luteinizing hormone, prolactin, and cortisol in normal men. J Clin Endocrinol Metab. 1980;51(6):1365–1371.
   PubMed Web of Science ®Google Scholar
• Piro C, Fraioli F, Sciarra F, et al. Circadian rhythm of plasma testosterone, cortisol and gonadotropins in normal male subjects. J Steroid Biochem. 1973;4(3):321–329.
   PubMedGoogle Scholar
• Kuzawa CW, Georgiev AV, McDade TW, et al. Is there a testosterone awakening response in humans? Adapt Human Behav Physiol. 2016;2:166–183.
   Google Scholar
• Buijs RM, van Eden CG, Goncharuk VD, et al. The biological clock tunes the organs of the body: timing by hormones and the autonomic nervous system. J Endocrinol. 2003;177(1):17–26. doi: 10.1677/joe.0.1770017.
   PubMed Web of Science ®Google Scholar
• Kalsbeek A, Perreau-Lenz S, Buijs RM. A network of (autonomic) clock outputs. Chronobiol Int. 2006;23(3):521–535. doi: 10.1080/07420520600651073.
   PubMed Web of Science ®Google Scholar
• Perreau-Lenz S, Pévet P, Buijs RM, et al. The biological clock: the bodyguard of temporal homeostasis. Chronobiol Int. 2004;21(1):1–25.
   PubMed Web of Science ®Google Scholar
• Ulrich-Lai YM, Arnhold MM, Engeland WC. Adrenal splanchnic innervation contributes to the diurnal rhythm of plasma corticosterone in rats by modulating adrenal sensitivity to ACTH. Am J Physiol Regul Integr Comp Physiol. 2006;290(4):R1128–1135.
   PubMed Web of Science ®Google Scholar
• Fries E, Dettenborn L, Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int J Psychophysiol. 2009;72(1):67–73. doi: 10.1016/j.ijpsycho.2008.03.014.
   PubMed Web of Science ®Google Scholar
• de la Iglesia HO, Blaustein JD, Bittman EL. The suprachiasmatic area in the female hamster projects to neurons containing estrogen receptors and GnRH. Neuroreport. 1995;6(13):1715–1722. doi: 10.1097/00001756-199509000-00004.
   PubMed Web of Science ®Google Scholar
• van der Beek EM, Horvath TL, Wiegant VM, et al. Evidence for a direct neuronal pathway from the suprachiasmatic nucleus to the gonadotropin-releasing hormone system: combined tracing and light and electron microscopic immunocytochemical studies. J Comp Neurol. 1997;384(4):569–579.
   PubMed Web of Science ®Google Scholar
• Watson RE, Jr, Langub MC, Jr, Engle MG, et al. Estrogen-receptive neurons in the anteroventral periventricular nucleus are synaptic targets of the suprachiasmatic nucleus and peri-suprachiasmatic region. Brain Res. 1995;689(2):254–264. doi: 10.1016/0006-8993(95)00548-5.
   PubMed Web of Science ®Google Scholar
• Kalsbeek A, Buijs RM. Output pathways of the mammalian suprachiasmatic nucleus: coding circadian time by transmitter selection and specific targeting. Cell Tissue Res. 2002;309(1):109–118. doi: 10.1007/s00441-002-0577-0.
   PubMed Web of Science ®Google Scholar
• Gerendai I, Banczerowski P, Halász B. Functional significance of the innervation of the gonads. Endocrine. 2005; 20528(3):309–318. doi: 10.1385/ENDO:28:3:309.
   PubMed Web of Science ®Google Scholar
• Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992;267(9):1244–1252. doi: 10.1001/jama.1992.03480090092034.
   PubMed Web of Science ®Google Scholar
• Faiman C, Winter JS. Diurnal cycles in plasma FSH, testosterone and cortisol in men. J Clin Endocrinol Metab. 1971;33(2):186–192.
   PubMed Web of Science ®Google Scholar
• Doerr P, Pirke KM. Cortisol-induced suppression of plasma testosterone in normal adult males. J Clin Endocrinol Metab. 1976;43(3):622–629.
   PubMed Web of Science ®Google Scholar
• Carstensen H, Amér B, Amér I, et al. The postoperative decrease of plasma testosterone in man, after major surgery, in relation to plasma FSH and LH. J Steroid Biochem. 1976;4(1):45–55.
   Google Scholar
• Sanchez-Guijo A, Neunzig J, Gerber A, et al. Role of steroid sulfatase in steroid homeostasis and characterization of the sulfated steroid pathway: evidence from steroid sulfatase deficiency. Mol Cell Endocrinol. 2016;437:142–153.
   PubMed Web of Science ®Google Scholar
• Kudielka BM, Kirschbaum C. Awakening cortisol responses are influenced by health status and awakening time but not by menstrual cycle phase. Psycho­neuroendocrinology. 2003;28(1):35–47. doi: 10.1016/s0306-4530(02)00008-2.
   PubMed Web of Science ®Google Scholar
• Hofman MA, Zhou JN, Swaab DF. Suprachiasmatic nucleus of the human brain: an immunocytochemical and morphometric analysis. Anat Rec. 1996;244(4):552–562.
   PubMedGoogle Scholar
• Lee HS, Billings HJ, Lehman MN. The suprachiasmatic nucleus: a clock of multiple components. J Biol Rhythms. 2003;18(6):435–449. doi: 10.1177/0748730403259106.
   PubMed Web of Science ®Google Scholar
• Christian CA, Moenter SM. Vasoactive intestinal polypeptide can excite gonadotropin-releasing hormone neurons in a manner dependent on estradiol and gated by time of day. Endocrinology. 2008;149(6):3130–3136. doi: 10.1210/en.2007-1098.
   PubMed Web of Science ®Google Scholar
• Jones JR, Chaturvedi S, Granados-Fuentes D, et al. Circadian neurons in the paraventricular nucleus entrain and sustain daily rhythms in glucocorticoids. Nat Commun. 2021;12(1):5763. doi: 10.1038/s41467-021-25959-9.
   PubMed Web of Science ®Google Scholar
• Teclemariam-Mesbah R, Kalsbeek A, Pevet P, et al. Direct vasoactive intestinal polypeptide-containing projection from the suprachiasmatic nucleus to spinal projecting hypothalamic paraventricular neurons. Brain Res. 1997;748(1-2):71–76. doi: 10.1016/s0006-8993(96)01246-2.
   PubMed Web of Science ®Google Scholar
• Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in Middle-aged and elderly men. N Engl J Med. 2010;363(2):123–135. doi: 10.1056/NEJMoa0911101.
   PubMed Web of Science ®Google Scholar
• Morley JE, Hm3Rd P, Patrick P, et al. Validation of salivary testosterone as a screening test for male hypogonadism. Aging Male. 2006;9(3):165–169.
   PubMed Web of Science ®Google Scholar
• Morales A, Spevack M, Emerson L, et al. Adding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry. Aging Male. 2007;10(2):57–65.
   PubMed Web of Science ®Google Scholar
• Tancredi A, Reginster JY, Luyckx F, et al. No major month to month variation in free testosterone levels in aging males. Minor impact on the biological diagnosis of ‘andropause. Psychoneuroendocrinology. 2005;30(7):638–646. doi: 10.1016/j.psyneuen.2005.02.002.
   PubMed Web of Science ®Google Scholar
• Tsujimura A, Matsumiya K, Miyagawa Y, et al. Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis. Int J Impot Res. 2005;17(3):259–263. doi: 10.1038/sj.ijir.3901300.
   PubMed Web of Science ®Google Scholar
• Travison TG, Araujo AB, Kupelian V, et al. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab. 2007;92(2):549–555. doi: 10.1210/jc.2006-1859.
   PubMed Web of Science ®Google Scholar